Mark Keegan is currently the Global Head of Drug Substance Development at Sanofi's mRNA Center of Excellence. They previously held positions as Vice President of Process and Analytical Development at Translate Bio, Vice President of Process Development and Manufacturing at Tidal Therapeutics and Selecta Biosciences, and Senior Project Engineer at ERM. Mark earned an M.S. in Engineering from Northeastern University and a B.S. in Chemical Engineering from Brown University. Their extensive background spans over two decades in process development and manufacturing within the biopharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices